Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03471260 |
| Title | Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | M.D. Anderson Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center | RECRUITING | Cleveland | Ohio | 44195 | United States | Details |
| Oregon Health and Science University | RECRUITING | Portland | Oregon | 97239 | United States | Details |
| M D Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |